The Besser lab is specialized in the clinical production of CAR T cells and Tumor Infiltrating Lymphocytes (TIL) for therapy of cancer patients.
Adoptive cell therapy serves as a platform for a wide range of research projects, which mainly seek the understanding and improvement of cellular therapies and immunotherapy.
Research activities include among others the development of off-the-shelf CAR T cells, new constructs for CAR T cells, identification of neo-antigen reactive T cells and the search for predictive markers of clinical response.
Dr. Michal Besser PhD
Sheba Medical Center